US 9320793
Method for treating a disease associated with soluble, oligomeric species of amyloid beta 1-42
granted A61KA61K2039/505A61K39/3955
Quick answer
US patent 9320793 (Method for treating a disease associated with soluble, oligomeric species of amyloid beta 1-42) held by Acumen Pharmaceuticals, Inc. expires Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Acumen Pharmaceuticals, Inc.
- Grant date
- Tue Apr 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61K, A61K2039/505, A61K39/3955, A61K45/06, A61P